European Reference Laboratory Network for TB (ERLTB-Net)
The ERLTB-Net sub-network of reference laboratories from EU/EEA Member States supports harmonisation of methods and laboratory capacity for tuberculosis diagnosis, antimicrobial susceptibility testing and typing in the EU/EEA.
Drug-resistant Tuberculosis continues to spread: new report. Concern about childhood TBArchived
A new report, Tuberculosis surveillance in Europe 2009, a joint publication from ECDC and the WHO Regional Office for Europe to mark World Tuberculosis Day 2011, provides evidence for concern about the spread of multi-drug resistant tuberculosis (MDR TB) and the persistence of TB among children.
Antimicrobial resistance - Tuberculosis
In EU, only 1 in every 3 MDR TB patients has a successful treatment outcome; more than half either die, fail treatment or default (stop taking treatment). XDR TB has even worse treatment outcomes: only 1 in 4 patients finishes treatment successfully.
Key messages - Drug-resistant tuberculosis
TB is slowly declining but MDR and XDR TB pose a serious challenge in the attempt to eliminate TB across Europe.
Every hour 30 people are diagnosed with tuberculosis in the European Region. It’s time to make TB a disease of the past
The latest ECDC/WHO report Tuberculosis surveillance and monitoring in Europe 2019 (2017 data) shows that despite an overall decline in numbers of people suffering from TB, the disease remains a major public health challenge in the Region.
External quality assessment for tuberculosis diagnosis and drug resistance in the European union: A five year multicentre implementation study
Nikolayevskyy, V., Hillemann, D., Richter, E., Ahmed, N., Van Der Werf, M.J., Kodmon, C., Drobniewski, F., Ruesch-Gerdes, S.
Childhood multidrug-resistant tuberculosis in the European union and European economic area: An analysis of tuberculosis surveillance data from 2007 to 2015
Ködmön, C., van den Boom, M., Zucs, P., van der Werf, M.J.
ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update
Migliori,G.B., Sotgiu,G., Rosales-Klintz, S., Centis, R., D'Ambrosio, L., Abubakar, I., Bothamley, G., Caminero, J. A., Cirillo, D.M., Dara, M., de Vries, G., Aliberti, S., Dinh-Xuan, A.T., Duarte, R., Midulla, F., Solovic, I., Subotic, D.R., Amicosante, M., Correia, A.M., Cirule, A., Gualano, G., Kunst, H., Palmieri, F., Riekstina, V., Tiberi, S., Verduin, R., van der Werf, M.J.
European Union standard for tuberculosis care on treatment of multidrug-resistant tuberculosis following new World Health Organization recommendations
Migliori, G.B., Sotgiu, G., Rosales-Klintz, S., van der Werf, M.J.
Isoniazid (INH) mono-resistance and tuberculosis (TB) treatment success: Analysis of European surveillance data, 2002 to 2014
Karo, B., Kohlenberg, A., Hollo, V., Duarte, R., Fiebig, L., Jackson, S., Kearns, C., Ködmön, C., Korzeniewska-Kosela, M., Papaventsis, D., Solovic, I., van Soolingen, D., van der Werf, M.J.